BCL2 and cancer: Some proteins showed a prominent position in each pathway, characterized by a high number of degrees, i.e. interactions (also named “molecular hubs”), like BCL2, BCL2L1 and FAS (Apoptosis pathway), TP53 (Cancer pathway), FDFT1 (Lipoprotein signaling and cholesterol metabolism pathway), GSR (Drug metabolism pathway) and CTNNB1 (Wnt pathway).